Rajesh Shrotriya - May 25, 2022 Form 4 Insider Report for CASI Pharmaceuticals, Inc. (CASI)

Role
Director
Signature
/s/Alexander A. Zukiwski, attorney-in-fact for Rajesh C. Shrotriya
Stock symbol
CASI
Transactions as of
May 25, 2022
Transactions value $
$0
Form type
4
Date filed
5/26/2022, 04:11 PM
Previous filing
Jun 16, 2021
Next filing
Jul 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Stock Option (Right to Buy) Award $0 +346K $0.00 346K May 25, 2022 Common Stock 346K $0.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option award will vest ratably quarterly to the end of the year.

Remarks:

Exhibit 24 - Power Of Attorney